Search results
Results From The WOW.Com Content Network
Equine polysaccharide storage myopathy (EPSM, PSSM, EPSSM) is a hereditary glycogen storage disease of horses that causes exertional rhabdomyolysis.It is currently known to affect the following breeds American Quarter Horses, American Paint Horses, Warmbloods, Cobs, Dales Ponies, Thoroughbreds, Arabians, New Forest ponies, and a large number of Heavy horse breeds.
Limb girdle muscular dystrophies (LGMD) as defined by the European Neuromuscular Centre in 2018. [1] [2] They are named by the following system: LGMD, recessive or dominant inheritance (R or D), order of discovery (number), affected protein.
Appropriate treatment for lameness depends on the condition diagnosed, but at a minimum it usually includes rest or decreased activity and anti-inflammatory medications. Other treatment options, such as corrective shoeing, joint injections, and regenerative therapies, are pursued based on the cause of lameness and the financial limits of the owner.
The same should be done when cooling down. Ensure that the horse is cared for, for an issues to the immune system and allowed to recover before continuing training. [1] A horse ideally should receive exercise once, or possibly twice a day, every day, to prevent the recurrence of ER. If possible, avoid breaks in the horse's exercise schedule. [1]
Equine encephalosis virus; Equine exertional rhabdomyolysis; Equine gastric ulcer syndrome; Equid alphaherpesvirus 1; Equid alphaherpesvirus 3; Equine infectious anemia; Equine influenza; Equine melanoma; Equine multinodular pulmonary fibrosis; Equine polysaccharide storage myopathy; Equine protozoal myeloencephalitis; Equine proximal enteritis ...
Equine protozoal myeloencephalitis in various stages. Equine protozoal myeloencephalitis (EPM) is a disease that affects the central nervous system of horses.It is caused by a protozoal infection that is brought about by the apicomplexan parasites Sarcocystis neurona or Neospora hughesi.
[4] [3] On single-fiber examination, features may include increased jitter (seen in other diseases of neuromuscular transmission) and blocking. [ 4 ] Blood tests may be performed to exclude other causes of muscle disease (elevated creatine kinase may indicate a myositis , and abnormal thyroid function tests may indicate thyrotoxic myopathy ).
TREAT-NMD (Translational Research in Europe, Assessment and Treatment for NeuroMuscular Disorders) is a global academic network that focuses on advancing research in neuromuscular disorders. [1] It was established in 2007 with its coordination centre at the Newcastle University . [ 2 ]